| TG THERAPEUTICS DL -,001 | 
| USA | 
| Gesundheit | 
| US88322Q1085 / A1JXW7 | 
| NKB2 (Frankfurt) / TGTX (NASDAQ) | 
| FRA:NKB2, ETR:NKB2, NKB2:GR, NASDAQ:TGTX | 
| - | 
| http://www.tgtherapeutics.. | 
| 
            TG Therapeutics, Inc. is a biopharmaceutical compa..
             >Volltext..  | 
      
| 4790.73 Mio. EUR | 
| 4792.3 Mio. EUR | 
| 394.19 Mio. EUR | 
| 74.74 Mio. EUR | 
| 52.49 Mio. EUR | 
| 0.36 EUR | 
| 220.26 Mio. EUR | 
| 112.1 Mio. EUR | 
| -51.33 Mio. EUR | 
| 1.47 | 
| 19.08% | 
| -42.55% | 
| - | 
| - | 
| - | 
| - | 
| TG THERAPEUTICS, TG THERAPEUTIC, TG THERA | 
| 04.11.25 | 
      
  | 
||||
      
  | 
||||
      
  | 
||||
      
  | 
||||
      
  | 
||||
      
  | 
||||
      
  | 
||||
      
  |